• 1. Evolution study of photo-synthesized gold nanoparticles by spectral deconvolution model: a quantitative approach
  Chung-Sung Yang,Mong-Shian Shih,Fang-Yi Chang New J. Chem., 2006,30, 729-735
• 2. Evidence of rutile-to-anatase photo-induced electron transfer in mixed-phase TiO2 by solid-state NMR spectroscopy?
  Weili Dai,Guangjun Wu,Michael Hunger Chem. Commun., 2015,51, 13779-13782
• 3. Fast-Track to Research Data Management in Experimental Material Science-Setting the Ground for Research Group Level Materials Digitalization.
  LarsBanko,AlfredLudwig
• 4. Evolution of cellulose into flexible conductive green electronics: a smart strategy to fabricate sustainable electrodes for supercapacitors
  Tengfei Yu,Yuehan Wu,Wei Li,Bin Li RSC Adv., 2014,4, 34134-34143
• 5. Evolutionary de novo design of phenothiazine derivatives for dye-sensitized solar cells?
  Vishwesh Venkatraman,Marco Foscato,Vidar R. Jensen,Bj?rn K?re Alsberg J. Mater. Chem. A, 2015,3, 9851-9860

Introduction to (7-Chloroquinolin-3-yl)boronic Acid (CAS No. 1370040-83-7)

(7-Chloroquinolin-3-yl)boronic acid, also known as 7-chloroquinolin-3-boronic acid, is a versatile and highly functionalized compound with significant applications in organic synthesis, medicinal chemistry, and materials science. This compound, with the CAS number 1370040-83-7, has garnered considerable attention due to its unique structural features and reactivity. The molecule consists of a quinoline ring system substituted with a chlorine atom at the 7-position and a boronic acid group at the 3-position. This combination of functional groups makes it an ideal building block for various cross-coupling reactions, particularly the Suzuki-Miyaura coupling, which is widely used in the construction of biaryl compounds.

Recent advancements in organoboron chemistry have further highlighted the potential of (7-chloroquinolin-3-yl)boronic acid in drug discovery and material synthesis. For instance, researchers have utilized this compound to develop novel antiviral agents by incorporating it into complex heterocyclic frameworks. The quinoline moiety is well-known for its biological activity, and the presence of the boronic acid group allows for precise functionalization through transition-metal-catalyzed reactions. This dual functionality has made it a valuable tool in the synthesis of bioactive molecules, including kinase inhibitors and G-protein coupled receptor (GPCR) modulators.

One of the most notable applications of (7-chloroquinolin-3-yl)boronic acid is its role in the construction of advanced materials. By incorporating this compound into polymer frameworks, scientists have developed materials with enhanced electronic properties. For example, studies have demonstrated that films synthesized using this compound exhibit improved charge transport characteristics, making them suitable for use in organic light-emitting diodes (OLEDs) and flexible electronics.

The synthesis of (7-chloroquinolin-3-yl)boronic acid involves a multi-step process that typically begins with the preparation of 7-chloroquinoline. This intermediate is then subjected to boronate esterification or direct boronation to introduce the boronic acid group. Recent developments in catalytic methods have enabled more efficient and selective syntheses, reducing production costs and improving yields. These advancements have made (7-chloroquinolin-3-yl)boronic acid more accessible to researchers worldwide.

In terms of pharmacological applications, this compound has shown promise as a precursor for drug candidates targeting various diseases. For instance, derivatives of this compound have been evaluated for their anti-inflammatory and anticancer activities. The chlorine substituent at the 7-position contributes to the molecule's lipophilicity, enhancing its ability to cross cellular membranes and interact with target proteins. Additionally, the boronic acid group facilitates further modifications, allowing researchers to fine-tune the compound's pharmacokinetic properties.

From an environmental standpoint, (7-chloroquinolin-3-yl)boronic acid has been studied for its potential use in green chemistry applications. Its ability to participate in catalytic cycles without generating harmful byproducts aligns with sustainable chemistry principles. Researchers are exploring its use in asymmetric synthesis and enantioselective reactions, which are critical for producing chiral pharmaceuticals with high enantiomeric excess.

In conclusion, (7-chloroquinolin-3-yl)boronic acid (CAS No. 1370040-83-7) is a multifaceted compound with wide-ranging applications across various scientific disciplines. Its unique structure, reactivity, and compatibility with modern synthetic techniques make it an invaluable tool for researchers aiming to develop innovative solutions in medicine, materials science, and beyond.

• 191162-39-7((quinolin-3-yl)boronic acid)
• 452972-10-0((4-chloropyridin-3-yl)boronic acid)
• 677702-23-7(Isoquinolin-4-ylboronic acid hydrochloride)
• 745784-09-2((4-chloro-3-quinolinyl)-Boronic acid)
• 128676-84-6((2-chloroquinolin-3-yl)boronic acid)
• 210889-31-9((1H-Indol-7-yl)boronic acid)
• 850568-71-7(Quinoline-3-boronic Acid Hydrochloride)
• 936940-92-0(7-Chloroquinoline-4-boronic Acid)
• 1072945-69-7(4-Chloropyridine-3-boronic acid hydrochloride)
• 86-58-8(quinolin-8-ylboronic acid)